These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3113140)
21. [The 3d catecholamine--dopamine]. Sotskova TV Klin Med (Mosk); 1970 Apr; 48(4):117-20. PubMed ID: 4915309 [No Abstract] [Full Text] [Related]
22. [Effect of reflexotherapy on the functional state of the sympathoadrenal system in patients with bronchial asthma]. Markelova VF; Osipova NN; Belitskaia RA; Gul'iants ER Vopr Med Khim; 1983; 29(4):106-9. PubMed ID: 6623987 [TBL] [Abstract][Full Text] [Related]
23. [Assessment of the functional state and sympatho-adrenal system by dopamine and dopa excretion in the urine]. Matlina ESh; Gugutishvili TsG; Kiseleva ZM; Kolesova DV; Sofieva IE Probl Endokrinol (Mosk); 1968; 14(1):15-9. PubMed ID: 5736988 [No Abstract] [Full Text] [Related]
24. [Possibilities and limitations of intensive therapy in severe craniocerebral injuries]. Kretschmer H Aktuelle Traumatol; 1983 Aug; 13(4):139-44. PubMed ID: 6138955 [TBL] [Abstract][Full Text] [Related]
25. Treatment of Parkinson's disease: levodopa as the first choice. Katzenschlager R; Lees AJ J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059 [TBL] [Abstract][Full Text] [Related]
26. [A comprehensive method of determining catecholamines, DOPA and 5-hydroxyindoleacetic acid in urine]. Nikiragina GP; Khoreva SA Lab Delo; 1988; (9):8-11. PubMed ID: 2461495 [No Abstract] [Full Text] [Related]
27. [Catecholamine metabolism in Huntington's chorea (in patients and their phenotypically healthy relatives)]. Magalov ShI; Dadali EL Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(8):1158-63. PubMed ID: 6452012 [TBL] [Abstract][Full Text] [Related]
28. Dopamine agonists in 6-pyruvoyl tetrahydropterin synthase deficiency. Porta F; Mussa A; Concolino D; Spada M; Ponzone A Neurology; 2009 Aug; 73(8):633-7. PubMed ID: 19704083 [TBL] [Abstract][Full Text] [Related]
29. [The effect of alpha-DOPA on the dynamics of urinary excretion of DOPA, catecholamines and their metabolites in healthy subjects and in patients with parkinsonism]. Matlina ESh; Kandel' EI; Vasil'ev VN; Iadgarov IS; Bol'shakova TD Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):205-9. PubMed ID: 4743269 [No Abstract] [Full Text] [Related]
30. [Administration of the catecholamine precursor, L-DOPA, for evaluating their in vivo biosynthesis in hypertension]. Kiseleva ZM; Parfenova EV; Erina EV; Shkhvatsabaia IK Kardiologiia; 1979 Oct; 19(10):55-60. PubMed ID: 502171 [TBL] [Abstract][Full Text] [Related]
31. [Trans-cerebral electrophoresis of L-DOPA in the complex treatment of parkinsonism]. Neĭmark EZ; Evtushenko SK; Dukhovnaia MA Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1334-8. PubMed ID: 6506979 [TBL] [Abstract][Full Text] [Related]
32. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients. Maruyama W; Naoi M; Narabayashi H J Neurol Sci; 1996 Jul; 139(1):141-8. PubMed ID: 8836986 [TBL] [Abstract][Full Text] [Related]
33. [Evaluation of the usefulness for measuring catecholamines and their principle metabolites in the diagnosis of pheochromocytoma]. Wocial B; Januszewicz W; Gryglas P; Januszewicz A; Feltynowski T; Lapiński M Przegl Lek; 1997; 54(11):793-8. PubMed ID: 9501691 [TBL] [Abstract][Full Text] [Related]
34. [Comparative evaluation of catecholamine and dopa content in dermatoses]. Broér BA Lab Delo; 1980; (4):224-6. PubMed ID: 6155548 [No Abstract] [Full Text] [Related]
35. [Functional state of the sympatho-adrenal system in children with infectious nonspecific polyarthritis]. Kolesov DV; Uvarova NN; Maslova OI Vopr Revm; 1968; 8(2):67-71. PubMed ID: 5742812 [No Abstract] [Full Text] [Related]
36. [Clinico-pathogenetic variants of DIC syndrome in patients with severe craniocerebral trauma]. Churliaev IuA; Lychev VG; Epifantseva NN; Afanas'ev AG Anesteziol Reanimatol; 1999; (3):35-7. PubMed ID: 10458036 [TBL] [Abstract][Full Text] [Related]
37. [Catecholamine excretion in children with neurogenic tumors of the mediastinum]. Stepanov EA; Bukhny AE; Bol'shakova TD; Lukicheva TI Khirurgiia (Mosk); 1972 Jun; 48(6):125-8. PubMed ID: 5043043 [No Abstract] [Full Text] [Related]
38. [Biogenic amine metabolism in patients with oligophrenia of different origins]. Bulakhova LA; Usherenko LS Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(10):1563-7. PubMed ID: 6229120 [TBL] [Abstract][Full Text] [Related]
39. [Various features of dopamine metabolism in schizophrenia]. Anokhina IP; Kogan BM Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(9):1343-7. PubMed ID: 6798791 [TBL] [Abstract][Full Text] [Related]
40. [Excretion of catecholamines and their precursors with the urine in patients with infectious nonspecific (rheumatoid) polyarthritis]. Frenkel' ID; Kalandarov SK; Fiveĭskaia AA Ter Arkh; 1969 Sep; 41(9):40-3. PubMed ID: 5396447 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]